Ribosomal protein L12 pseudogene 6 (RPL12P6)

Ribosomal protein L12 pseudogene 6 is a pseudogene—a non-functional genomic DNA sequence similar to the ribosomal protein L12 (RPL12) gene but not encoding a functional protein[11][13][5]. Pseudogenes like RPL12P6 originate primarily through the retrotransposition or duplication of functional genes, followed by mutations that render them inactive[5]. RPL12P6 does not produce a functional ribosomal protein, and there is no evidence it serves as a receptor, enzyme, transporter, or any form of therapeutic target[11][13].\nFunctional RPL12 (not the pseudogene) is a structural component of the large (60S) ribosomal subunit, playing a central role in protein synthesis and translation, but the pseudogene has no known biological or disease relevance[4][6][7][13].\nKey points:\n- RPL12P6 is a pseudogene and not an active gene; it does not encode a functional protein or act as a therapeutic target[5][13][11].\n- Pseudogenes like RPL12P6 have no known biological or disease function, do not interact with drugs, and are not used as biomarkers or therapeutic targets in practice[5][13].\n- Frequently, processed pseudogenes exist throughout the human genome for ribosomal proteins; these are relics of evolutionary duplication/retrotransposition and are generally biologically inert[5].\n- Pseudogenes may sometimes be annotated in gene or protein databases but do not encode proteins and are not valid drug targets[13].\nSummary regarding use as a therapeutic target:\nRPL12P6 (Ribosomal protein L12 pseudogene 6) is not a functional gene, has no pharmacological relevance, and should not be considered a drug target. There is nothing pharmacologically actionable or mechanistically significant about this pseudogene in human biology or disease[5][11][13].

Other names

RPL12_12_1352RPL12P6